258 related articles for article (PubMed ID: 24417754)
1. Structure identification and elucidation of mosapride metabolites in human urine, feces and plasma by ultra performance liquid chromatography-tandem mass spectrometry method.
Sun X; Zhao L; Niu L; Qin F; Lu X; Xiong Z; Li F
Xenobiotica; 2014 Aug; 44(8):734-42. PubMed ID: 24417754
[TBL] [Abstract][Full Text] [Related]
2. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS.
Sun X; Niu L; Li X; Lu X; Li F
J Pharm Biomed Anal; 2009 Aug; 50(1):27-34. PubMed ID: 19362796
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of mosapride and its active des-p-fluorobenzyl and 4'-N-oxide metabolites in rat plasma using UPLC-MS/MS: an application for a pharmacokinetic study.
Zhao L; Sun X; Xiong Z; Wang S
Talanta; 2015 May; 137():130-5. PubMed ID: 25770615
[TBL] [Abstract][Full Text] [Related]
4. The tissue distribution and excretion study of mosapride and its active des-p-fluorobenzyl and 4'-N-oxide metabolites in rats by ultra-high performance liquid chromatography-tandem mass spectrometry method.
Li K; Jiang X; Xiong Z; Qin F; Zhao L
Xenobiotica; 2020 Feb; 50(2):115-124. PubMed ID: 30883253
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
6. [Determination of mosapride in human plasma by high performance liquid chromatography tandem mass spectrometry].
Qin F; Chen LY; Ma YY; Wang D; Liu J; Lu XM; Li FM
Yao Xue Xue Bao; 2007 Aug; 42(8):882-5. PubMed ID: 17944240
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TPN729 metabolites in humans using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Zhu Y; Li L; Deng P; Chen X; Zhong D
J Pharm Biomed Anal; 2016 Jan; 117():217-26. PubMed ID: 26366939
[TBL] [Abstract][Full Text] [Related]
8. Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry.
Huang M; Lee YS; Ho PC
Rapid Commun Mass Spectrom; 2010 Mar; 24(6):729-41. PubMed ID: 20169560
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiles of 20(S)-protopanaxadiol in rats after oral administration using ultra-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.
He C; Li J; Wang R; Li Z; Bligh SW; Yang L; Wang Z
Rapid Commun Mass Spectrom; 2014 Mar; 28(6):595-604. PubMed ID: 24519822
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-tandem mass spectrometric method for determination of mosapride citrate in equine tissues.
Aoki Y; Hakamata H; Igarashi Y; Uchida K; Kobayashi H; Hirayama N; Kotani A; Kusu F
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):135-42. PubMed ID: 17851144
[TBL] [Abstract][Full Text] [Related]
11. Identification of metabolites of deoxyschizandrin in rats by UPLC-Q-TOF-MS/MS based on multiple mass defect filter data acquisition and multiple data processing techniques.
Liu M; Zhao S; Wang Z; Wang Y; Liu T; Li S; Wang C; Wang H; Tu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 949-950():115-26. PubMed ID: 24487041
[TBL] [Abstract][Full Text] [Related]
12. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
[TBL] [Abstract][Full Text] [Related]
13. Metabolite identification of bentysrepinine (Y101), a novel anti-HBV agent in rats using a five-step strategy based on a combined workflow with two different platforms of liquid chromatography-tandem mass spectrometry.
Fan H; Hu Z; Li R; Dong S; Gu Y; Liu T; Si D; Liang G; Liu C
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():118-128. PubMed ID: 27978466
[TBL] [Abstract][Full Text] [Related]
14. Metabolites identification of harmane in vitro/in vivo in rats by ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
Li S; Liu W; Teng L; Cheng X; Wang Z; Wang C
J Pharm Biomed Anal; 2014 Apr; 92():53-62. PubMed ID: 24486683
[TBL] [Abstract][Full Text] [Related]
15. Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry.
Lou Y; Zheng J; Wang B; Zhang X; Zhang X; Zeng S
J Ethnopharmacol; 2014; 151(1):242-52. PubMed ID: 24189033
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
Yoshida N; Omoya H; Kato S; Ito T
Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Profile of Skimmianine in Rats Determined by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Tandem Mass Spectrometry.
Huang A; Xu H; Zhan R; Chen W; Liu J; Chi Y; Chen D; Ji X; Luo C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28333075
[TBL] [Abstract][Full Text] [Related]
18. Quantification of pseudoephedrine in human plasma by LC-MS/MS using mosapride as internal standard.
Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Maurya S; Komarneni P
Biomed Chromatogr; 2007 Mar; 21(3):241-8. PubMed ID: 17230461
[TBL] [Abstract][Full Text] [Related]
19. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.
Liu Y; Yao X; Song L; Liu H; Zhao Q; Jiang J; Ni G; Shi C; Ma X; Zhou H; Liu D; Hu P
J Pharm Biomed Anal; 2018 Aug; 157():189-200. PubMed ID: 29803910
[TBL] [Abstract][Full Text] [Related]
20. Revealing the metabolic sites of atazanavir in human by parallel administrations of D-atazanavir analogs.
Cheng C; Vedananda S; Wu L; Harbeson S; Braman V; Tung R
J Mass Spectrom; 2013 Sep; 48(9):1019-31. PubMed ID: 24078243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
